Speech by Federal Chancellor Dr. Angela Merkel at the Future Congress on Health Economy of the Federal Ministry of Health on April 29, 2010, in Berlin:

Germany Angela Merkel · Former Chancellor of Germany

29 April 2010 · Future Congress on Health Economy of the Federal Ministry of Health · Berlin, Germany

Context
Merkel addressed the Future Congress on Health Economy in Berlin on April 29, 2010, discussing Germany's healthcare sector and broader economic recovery amid the European debt crisis.
Main themes
Health economy, German healthcare system, economic recovery, social market economy, labor market, budget consolidation, structural reforms, short-time work instrument, European debt crisis, Greece financial situation, long-term growth, public debt
Duration
~26 min
76th percentile
Words
3,059
76th percentile
Sentences
153
81st percentile
Readability
42
41st percentile
Grade
12.2
48th percentile
Syntax
3.04
53rd percentile
Vocabulary
2.01
12th percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Economic 65%65%
  • Social 22%22%
  • Ceremonial 8%8%
  • Institutional 5%5%
  • Geopolitical 1%1%
  • Technological 1%1%
  • Environmental 0%0%
  • Not in focus 0%

153 sentences in 36 paragraphs

Dear Minister, dear Philipp Rösler,

dear colleagues from the German Bundestag,

ladies and gentlemen,

when the Minister invited me to participate in this congress, I gladly accepted because I believe that the topic is of the utmost importance for the future and economic strength of our country and that the German healthcare system, as it has been presented, is of the highest quality. We are also proud that this healthcare system is intertwined with an associated economic sector that excels in all areas and that we can also strengthen.

Here, the temptation was expressed that I could apply for the title of Health Chancellor or Health Economy Chancellor. Given the imminent meeting on electromobility, I must be a bit cautious today. But perhaps one can also take care of all sectors of the German economy equally. Among them – I want to state this explicitly – the health economy holds a special significance; this is not only in my task catalog but also in my heart.

The question of how the health economy will proceed has, of course, a particular relevance and significance in the general economic discussion we are currently having. When we look at the overall economic situation, we must note that the economy contracted by five percent last year. Such a thing has never happened in the 60 years of the history of the Federal Republic of Germany. That was the impact of the international financial and economic crisis. We are glad that the situation is now characterized by growth since the second quarter of last year and that a growth forecast of 1.4 percent has been issued for the year 2010. This puts Germany above the average of the Eurozone. We must strengthen all areas where growth is possible. And that naturally includes the health economy.

We can say that in Germany, in this difficult situation, all actors have acted and reacted responsibly. Politics has made significant contributions with a rescue program for banks and with economic stimulus measures. Companies – whether medium-sized or large – have equally acted responsibly, for example, by making use of the short-time work instrument. And the employee representatives have felt particularly committed to the goal of preserving jobs. I believe this is a very, very good example that social market economy in our country is not just on paper, but that social market economy is also lived in Germany.

The results in the labor market are encouraging. I do not want to conceal that at the beginning of the economic crisis, I had significant concerns about how it would affect the number of unemployed and the employment situation. We are very pleased that the short-time work, which we have now extended again as a Christian-Liberal coalition, has proven to be very effective and that we were able to hear today about labor market figures that document an increase in employment compared to the previous year and that clearly show that a recovery is not only taking place in the area of economic growth but is also tangible for the people – and that is the most important thing.

However, in such a situation, where we want to emerge from the crisis and look to the future, we must also ensure that we strengthen our long-term growth forces. This also means that we must continually think about structural reforms in the labor market. I want to remind you that we have far too many long-term unemployed and that we must set performance incentives for people to emerge from long-term unemployment. In this regard, the federal government has recently made important decisions, especially concerning young employees, single parents, and older workers.

Strengthening growth forces also means secondly having solid finances. The economic stimulus measures have led to public debt being too high. However, Germany is the only country that has reacted to the crisis by writing a debt brake into the Basic Law and stating: In the coming years, budget consolidation is a very significant contribution for us.

In these days, we must also talk about budget consolidation and solid finances throughout Europe. This is a topic that certainly concerns us all. You will also, as I suspect, be closely monitoring the situation in Greece. Therefore, I want to reiterate unequivocally: Germany will help as soon as – I emphasize "as soon as" – the conditions are met. Intensive work is currently being done in Athens together with the International Monetary Fund, the EU Commission, and the European Central Bank. We can expect results in a few days. After that, we will also initiate a legislative process in Germany, but in the right order.

I know that all of this is painful; very painful indeed. It requires a lot of strength. But it primarily requires the strength to wait for the end of the negotiations in Greece. We must insist that overcoming the crisis is enforced through a comprehensible, credible, and also rigorous program, along with the corresponding analysis in Greece. Because we have experienced far too often – for example, in 2000 when Greece joined the Eurozone – that this was not done. Together with the entire federal government, I am firmly determined that we will lay the foundations for the future correctly at this point. The guarantee for this is the therapy developed by the IMF, the European Central Bank, and the EU Commission. I believe there is no reasonable alternative to this path. Of course, we will do everything to ensure the overall stability of the Euro. Because a secure, stable currency is just as much a hallmark as solid budgets are.

To strengthen growth forces, we also need performance incentives. We find these, for example, in a performance-oriented tax policy. Therefore, the topic of relieving smaller and medium incomes will be on our agenda just as much as the topic of solid finances and structural reforms in the labor market.

All of this are areas where our international competitiveness is decided. This is based, of course, in addition to these areas, on the innovative strength of our companies, on the commitment and qualifications of our employees, on the quality of our products – "Made in Germany" has been mentioned here today – and on our excellent networking with foreign markets.

German companies have made over 500 billion euros in direct investments in other EU countries and employ more than 2.7 million employees there. Therefore, the accusation that we are exacerbating imbalances through our export surplus is untenable because through our investments, which we make with the surpluses, and the jobs created outside Germany, we also make an important contribution to growth. I think we should strengthen our export economy – whether in the health economy or in all other areas.

In the Christian-Liberal coalition, we focus on research and innovation. This is also evident in the area of the health economy. The share of the health economy in gross domestic product is expected to grow from ten percent in 2005 to almost 13 percent in 2020 according to our forecasts. The number of employees has already been mentioned: Today, there are five million people. This number could grow to seven million. This means there is a great potential for employment with qualified work. This is work with people that can be very enjoyable, such as work with technology in the pharmaceutical or medical-technical field.

In the export strength of the sector, there are also enormous growth potentials. The OECD estimates that global sales of health economy products and services will increase to seven trillion US dollars by 2015. Within 15 years, this is more than a doubling compared to the year 2000. It would be quite a feat if Germany were to confidently earn a share of these great future opportunities. We have the corresponding companies in Germany.

German medical products, pharmaceuticals, medical technology, and hospital services are recognized trademarks worldwide. I want to emphasize once again that the logistics of operating hospitals and complex medical institutions is something of a trademark. I experience this repeatedly during my visits around the world. People prefer not only to build a hospital but also to have the entire logistics set up. Then they try to replicate what they may have experienced in medical care in Germany.

German medical technology is internationally very successful. In the global market for medical technology, German companies have an export rate of almost 65 percent. This is the second rank after the United States of America. Of course, we always want to politically support German companies and pick up on future trends. Therefore, we will bundle our foreign trade activities thematically more strongly. For example, the Federal Minister for Economic Affairs and Technology will develop a framework plan for foreign trade promotion in the area of the health economy to better interlink what the Minister has already mentioned. We know that travel related to the sale of our economic products is very, very successful – whether undertaken by the Minister of Economic Affairs, the Foreign Minister, the Chancellor, or others. The networking of political and friendly contacts with economic investments has always benefited our export economy.

The health economy has not only preserved its stabilizing influence despite the economic crisis but was certainly one of the beacons during this crisis. One can say that the entire sector has really held its ground well.

We know that in these areas, research expenditures or research investments are particularly important. They amount to about ten percent and are thus twice as high as the average of other sectors. Alongside a few sectors in the German economy, the health economy is therefore one that is absolutely research-intensive.

We are well positioned in this regard. We have placed the topic of education and research at the top of the agenda for our work in this legislative period. We want to achieve by 2015 that we spend ten percent of our gross domestic product on research and education. In the research area, we have already achieved the three percent target very well regarding the federal share. Here, the health economy is naturally one of our important partners because it exceeds its contribution with ten percent.

In this legislative period, we will provide an additional 12 billion euros solely for education and research. This is a substantial contribution from the federal government to achieve our common objectives, which are distributed among the federal government, states, and private entities. But money is, of course, not the only thing we need; we must also strategically plan the whole thing sensibly. Therefore, it is important that we further develop the high-tech strategy and align it more closely with the major challenges of the future. Therefore, the health economy will be one of the future focuses in this high-tech strategy. We want to strengthen the unique and leading potential of our research location in this area.

We are also looking to ensure that there are always interesting networks in the area of top clusters from the medical field. In the last round of the top cluster competition, alongside a biotech cluster, we also had a medical technology cluster, namely the Medical Valley European Metropolitan Region of Nuremberg, as a winner. I do not know how it is with the Valley in Nuremberg. When I drive past there, there are a few mountains in the distance. Be that as it may, we wish the Metropolitan Region of Nuremberg much success.

It becomes clear at this point that thinking in clusters will be very, very important in the future. When I was recently in a real valley, namely Silicon Valley – the visit was followed by a somewhat arduous return journey – I was able to convince myself that the key to success is essentially the networking of university locations, research institutions, and large and very innovative small companies. This requires significant financing. We certainly still have work to do here. Venture capital is not yet as established as it is in the United States. This also includes the mindset that one sometimes needs a second chance.

One of our major disadvantages in Germany is still that it is not a given that when one takes a risk and fails once and is not successful, one still has the courage to start again. This needs to be practiced and lived in our clusters. I believe we should focus on this. Particularly the very innovative and flexible healthcare sector could be a very good area for this.

We have network building not only in terms of research and development as well as production, but also in the area of disease treatment. I am thinking, for example, of degenerative dementias, diabetes, and much more. However, we also know that we can confidently further develop initiatives such as integrated research and treatment centers or the "Health Regions" competition to direct our attention to certain focal points: increasing the potentials of personalized medicine, strengthening prevention, ensuring patient care, and further combating common diseases. I believe that common diseases are one of the major challenges of a highly developed industrial society. Therefore, this also involves strategic and structural developments of the German centers for health research, which play a significant role in this context.

You see that the healthcare sector is not just an important area for the Minister of Health, but that we in the federal government – from the Ministry of Research to the Ministry of Economics to foreign activities and, of course, as always, the Chancellery – have a common interest in this area. I could also mention the Minister for Family Affairs and Senior Citizens and many others. Health is something that goes far beyond the actual department. Therefore, a heartfelt thank you for the initiative to convene such a congress.

Through our Central Innovation Program for SMEs, we have been able to provide many interesting impulses. I know that the issue of tax incentives for research services probably also plays an important role in the healthcare sector. We have, so to speak, an interesting culture of debate between those who expect too much side funding through tax incentives, meaning too little focused funding, and those who say: This is a location factor for Germany because in all our neighboring countries such tax incentives for research exist, and the research location Germany is thereby weakened. I personally lean towards the second variant – I say this explicitly – but significant voices in our coalition see it differently. So we can still use support from the healthcare sector here.

We will have a massive change in healthcare through the Internet and the possibilities of information and communication technology. I am following with interest the further steps in the introduction of a health card. The Federal Minister of Health has taken this matter in hand. If I have understood everything correctly, the focus is now on the essentials – not to say, on the minimal. As long as the name and date of birth are recorded, I am satisfied that we have at least made the initial step. I understood it that way, that further development work will be carried out step by step.

But I must tell you at this point: Germany is on the way to becoming somewhat slow in this area. When I met with the partner country Spain at CeBIT, it became clear that in Spain – according to everything the Spaniards have told me – both in terms of broadband access and the introduction of electronic identity cards and health cards, they are certainly not lagging behind what has been achieved in Germany so far.

I believe the Minister of Health spoke about how we need to change the relationship of the insured to the insurance companies or health funds towards a more self-confident relationship. I believe that transparency and the use of electronic possibilities will be part of this. Now I will be a bit polemical: Whoever can remember three PIN numbers can probably also manage to remember a fourth. If it really doesn't work, one must write these numbers down somewhere – I know, one is not supposed to do that – where no one can find them. In any case, we should not relent in our efforts to make progress here.

One thing I must also say to those who work in the healthcare sector: We in politics are obliged to ensure a functioning and accessible healthcare system of high quality for everyone. One of the areas where we can do this without the system needing more money – although overall it will need more money – is the area of transparency. I already know that living in incomplete transparency opens gaps and possibilities. But you must understand that it is not our task to maintain these possibilities, corners, and niches, but that it is our task – and that alone is the measure – to ensure that we succeed in providing patients with the necessary medical services that correspond to the state of medical knowledge. In this area, certain tension-filled discussions are sometimes unavoidable. I have also developed a certain ambition to become comparably knowledgeable in order to illuminate these corners and niches sometimes. Through the entire information and communication technology, this will certainly increase.

In addition to the health card, this also concerns the area of telemedicine, which brings incredible possibilities – also regarding the improvement of quality of life in rural areas – and which of course also provides a lot of security.

So we, as the federal government, as a Christian-liberal coalition, are politically on the way to strengthen the foundations for a modern, technically excellent healthcare system while simultaneously opening up all development opportunities for the associated sector, the associated economic area – whether domestically or through export opportunities.

Given the wonderful possibilities we have in the medical technology and pharmaceutical sectors, I believe that you, who represent the companies from this sector and who have come in large numbers today – thank you very much for that – reflect a piece of what the product "Made in Germany" represents in the 21st century. We are building on excellent foundations, but we still have quite a few development opportunities. Only together will we succeed in ensuring that this remains a showcase for Germany. I wish for this and am therefore happy to have come to this congress.